Humoral immunity after second dose of BNT162b2 vaccine in Japanese communities: an observational cross-sectional study, Fukushima Vaccination Community Survey
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2045-2322
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Humoral immunity after second dose of BNT162b2 vaccine in Japanese communities: an observational cross-sectional study, Fukushima Vaccination Community Survey ; volume:12 ; number:1 ; day:7 ; month:11 ; year:2022 ; pages:1-10 ; date:12.2022
Scientific reports ; 12, Heft 1 (7.11.2022), 1-10, 12.2022
- Urheber
-
Kobashi, Yurie
Kawamura, Takeshi
Shimazu, Yuzo
Zhao, Tianchen
Sugiyama, Akira
Nakayama, Aya
Kaneko, Yudai
Nishikawa, Yoshitaka
Omata, Fumiya
Takita, Morihito
Yamamoto, Chika
Yoshida, Makoto
Kosaka, Makoto
Murayama, Anju
Sugiura, Sota
Tanaka, Manato
Kawashima, Moe
Uchi, Yuna
Shindo, Joji
Oikawa, Tomoyoshi
Shibuya, Kenji
Kodama, Tatsuhiko
Tsubokura, Masaharu
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1038/s41598-022-21797-x
- URN
-
urn:nbn:de:101:1-2023012110233318453990
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:30 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Kobashi, Yurie
- Kawamura, Takeshi
- Shimazu, Yuzo
- Zhao, Tianchen
- Sugiyama, Akira
- Nakayama, Aya
- Kaneko, Yudai
- Nishikawa, Yoshitaka
- Omata, Fumiya
- Takita, Morihito
- Yamamoto, Chika
- Yoshida, Makoto
- Kosaka, Makoto
- Murayama, Anju
- Sugiura, Sota
- Tanaka, Manato
- Kawashima, Moe
- Uchi, Yuna
- Shindo, Joji
- Oikawa, Tomoyoshi
- Shibuya, Kenji
- Kodama, Tatsuhiko
- Tsubokura, Masaharu
- SpringerLink (Online service)
Ähnliche Objekte (12)
Impaired humoral immunity following COVID-19 vaccination in HTLV-1 carriers
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®)
Humoral response after BNT162b2 vaccine in Japanese hemodialysis patients
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series
Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2
Cross-reactive cellular and humoral immunity in heterologous SARS-CoV-2 vaccination
Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus
Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2: a 9 months longitudinal study
Phytogalactolipids activate humoral immunity against colorectal cancer
Sex differences in vaccine-induced humoral immunity
Impaired humoral immunity following COVID-19 vaccination in HTLV-1 carriers
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®)
Humoral response after BNT162b2 vaccine in Japanese hemodialysis patients
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series
Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2
Cross-reactive cellular and humoral immunity in heterologous SARS-CoV-2 vaccination
Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus
Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2: a 9 months longitudinal study
Phytogalactolipids activate humoral immunity against colorectal cancer
Sex differences in vaccine-induced humoral immunity
Impaired humoral immunity following COVID-19 vaccination in HTLV-1 carriers
Reactogenicity Correlates Only Weakly with Humoral Immunogenicity after COVID-19 Vaccination with BNT162b2 mRNA (Comirnaty®)
Humoral response after BNT162b2 vaccine in Japanese hemodialysis patients
Comprehensive assessment of humoral response after Pfizer BNT162b2 mRNA Covid-19 vaccination: a three-case series
Predictors of impaired SARS-CoV-2 immunity in healthcare workers after vaccination with BNT162b2
Cross-reactive cellular and humoral immunity in heterologous SARS-CoV-2 vaccination
Humoral Response to Pfizer BNT162b2 Vaccine Booster in Maintenance Hemodialysis Patients
Duration of humoral immunity from smallpox vaccination and its cross-reaction with Mpox virus
Influence of a Heterologous (ChAdOx1-nCoV-19/BNT162b2) or Homologous (BNT162b2/BNT162b2) Vaccination Regimen on the Antibody and T Cell Response to a Third Vaccination with BNT162b2
SARS-CoV-2 specific T cell and humoral immune responses upon vaccination with BNT162b2: a 9 months longitudinal study
Phytogalactolipids activate humoral immunity against colorectal cancer